CYTOMEGALOVIRUS (CMV) PREVENTION STRATEGIES IN SEROPOSITIVE KIDNEY TRANSPLANT (KT) RECIPIENTS RECEIVING ANTILYMPHOCYTE INDUCTION THERAPIES: DATA FROM A MULTICENTER COHORT STUDY (THE OPERA STUDY)

被引：0
|
作者：
Aguado, Jose M. [1 ]
Fernandez-Ruiz, Mario [1 ]
Arias, Manuel [2 ]
Campistol, Josep M. [3 ]
机构：
[1] Univ Hosp 12 Octubre, Infect Dis Unit, Madrid, Spain
[2] Univ Hosp Marques de Valdecilla, Dept Nephrol, Santander, Spain
[3] Hosp Clin IDIBAPS, Dept Nephrol & Renal Transplantat, Barcelona, Spain
来源：
TRANSPLANT INTERNATIONAL | 2013年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：29 / 29
页数：1
相关论文
共 23 条
  • [21] Migratory pattern of the coronavirus disease 2019 and high fatality rates among kidney transplant recipients: report from the Brazilian Multicenter Cohort Study
    Cristelli, Marina Pontello
    de Sandes-Freitas, Taina Veras
    Viana, Laila Almeida
    Requiao-Moura, Lucio R.
    de Andrade, Luis Gustavo Modelli
    Tedesco-Silva, Helio
    Medina-Pestana, Jose
    JORNAL BRASILEIRO DE NEFROLOGIA, 2022, 44 (03): : 428 - 433
  • [22] A controlled, comparative study of two regimens (750 mg bid and 500 mg bid) of oral gancilovir in the prevention of cytomegalovirus infection in post-kidney transplant ''CMV at risk'' recipients.
    Ahsan, N
    Holman, MJ
    OBrien, B
    Langhoff, EG
    Yang, HC
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A3129 - A3129
  • [23] Prevalence of CMV, JC and BK Viruses in Renal Transplant Recipients Receiving Induction with Alemtuzumab or Basiliximab - Interim Analysis from the SALAMI Study (Steroid Avoidance in Leeds with Alemtuzumab or MMF Immunosuppression).
    Sajid, S.
    Cherukuri, A.
    Sandhu, B.
    Hale, A.
    Baker, Richard
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 680 - 680
123